
www.Usenet.com
| <-- __Chronological__ --> | <-- __Thread__ --> |
HIV Nutrition News Update - Iss. 3, No. 104, Oct 17, 2003 The HIV Nutrition News Update is a free weekly review of news related to nutrition and HIV/AIDS made possible through the sponsorship of A1WebServer <http://www.a1webserver.com> and HIV ReSources, Inc. Copyright and subscription information appears at the end of this update. Early issues of the update are available through the HIV ReSources web site at <http://hivresources.com/mailman/listinfo/hivnutritionnewsupdatelist_hivresources.com> and <http://www.hivresources.com/Archive1.html>. HIV/AIDS Resources * The Winter 2003 edition of "Positively Aware" (nutrition issue) is available in Spanish <http://www.tpan.com/publications/positively_aware_en_espanol/pa_espanol.html>. * The Henry J. Kaiser Family Foundation and The Jacobs Institute of Women’s Health offer "Women’s Health Data Book: A Profile of Women’s Health in the United States"<http://www.kff.org/content/2001/6004>. Individual copies of this publication (#6004) may be obtained by calling the Foundation's publication request line at 800/656-4533. Multiple copies may be obtained from the Jacobs Institute by calling 202/863-4990. * "Health Care and HIV: Nutritional Guide for Providers and Clients" is available online at <http://www.aids-etc.org>. Post-Publication News - Leptin And Adiponectin Recently published information on leptin and lipodystrophy adds to that found in the Update Central column published in Issue 41 of the HIV Nutrition Update <http://www.hivresources.com/Selenium.PDF>. Increasingly more sources are noting that leptin may play a role in HIV-related lipodystrophy. Murine studies suggest that leptin replacement therapy may help to reduce metabolic abnormalities associated with the treatment of HIV by highly active antiretroviral therapy (HAART). (1) Murine studies of leptin treatment also suggest that insulin up-regulates and leptin down-regulates adipocyte fatty acid uptake, leading to alterations in fatty acid partitioning that affect fat cells. (2) Lipodystrophy patients have significantly reduced plasma leptin levels and leptin replacement therapy may reduce hepatic fat mass and improve insulin sensitivity. (3) Preliminary studies by Nagy and colleagues working in Boston report that after controlling for total and regional body fat, significantly reduced leptin levels in HIV-positive patients with lipoatrophy were independently associated with insulin resistance. (4) Sutinen and others report the severity of insulin resistance in HAART patients correlates with fat accumulation in the liver. (3) Investigators note leptin-induced improvements in insulin sensitivity accompanied by reductions in intrahepatic and intramyocellular lipid accumulation. (5) We know that leptin plays a role in energy homeostasis and now investigators are attempting to determine if it influences bone development and remodeling. Preliminary data from two women showed that subcutaneous leptin replacement therapy had no effect on bone in hypoleptinemic patients with generalized lipodystrophy. (6) Adiponectin is a fat cell-secreted protein that acts to increase insulin sensitivity. As in a murine model of lipodystrophy, patients on HAART with fat redistribution may have decreased levels of adiponectin. (7) In some HIV-positive patients treated with HAART, adiponectin is directly correlated with high-density lipoprotein cholesterol and extremity fat and inversely correlated with abdominal visceral fat mass, serum triglycerides, and insulin resistance. Addy and others note the use of non-nucleoside reverse transcriptase inhibitors may worsen insulin resistance by decreasing adiponectin levels. These investigators report that adiponectin treatment improves metabolic syndrome in adiponectin deficient mice. Although there may be a link between adiponectin, central obesity and insulin resistance there is no association between serum adiponectin and leptin. (8) Gavrila and colleagues report that neither fasting for two days, which results in a low leptin state, nor leptin administration alters serum adiponectin levels in women without a known history of diabetes. References 1. Riddle TM, et al. Leptin Replacement Therapy but not Dietary Polyunsaturated Fatty Acid Alleviates HIV Protease Inhibitor-Induced Dyslipidemia and Lipodystrophy In Mice. JAIDS 2003;33(5):564-70. 2. Fan X, et al. Leptin and Insulin Modulate Nutrient Partitioning and Weight Loss in ob/ob Mice through Regulation of Long-Chain Fatty Acid Uptake by Adipocytes. J Nutr 2003;133:2707-2715. 3. Sutinen J, et al. Increased Fat Accumulation in the Liver in HIV-Infected Patients with Antiretroviral Therapy-Associated Lipodystrophy. AIDS 2002;16(16):2183-93. 4. Nagy GS, et al. Human Immunodeficiency Virus Type 1 Related Lipoatrophy and Lipohypertrophy Are Associated with Serum Concentrations of Leptin. CID 2003;36(6):795-802. 5. Simha V, et al. Effect of Leptin Replacement on Intrahepatic and Intramyocellular Lipid Content in Patients With Generalized Lipodystrophy. Diabetes Care 2003;26(1):30-35. 6. Simha V, et al. Effect of Subcutaneous Leptin Replacement Therapy on Bone Metabolism in Patients With Generalized Lipodystrophy. J Clin Endocrinol Metab 2002;87(11):4942-5. 7. Addy CL, et al. Hypoadiponectinemia is Associated With Insulin Resistance, Hypertriglyceridemia, and Fat Redistribution in Human Immunodeficiency Virus-Infected Patients Treated With Highly Active Antiretroviral Therapy. J Clin Endocrinol Metab 2003;88(2):627-36. 8. Gavrila A, et al. Serum Adiponectin Levels Are Inversely Associated With Overall and Central Fat Distribution but Are Not Directly Regulated by Acute Fasting or Leptin Administration in Humans: Cross-Sectional and Interventional Studies. J Clin Endocrinol Metab 2003;88(10):4823-31. Editors Note: Although we focus on nutrition and HIV related issues the fight for affordable medications appears worth mentioning as it affects everyone. If you find the cost of prescribed medications unjustly high please view the Fight For Affordable Drugs Web Site at <http://www.affordabledrugs.il.gov/PetitionAction2.cfm>. All materials are protected by copyright and are the property of HIV ReSources or the parties credited as the provider of the content. This copyright notice must be used when reproducing any portion of this update: >From The HIV Nutrition News Update, Copyright 2003 HIV ReSources, Incorporated <http://www.hivresources.com>. To subscribe or unsubscribe visit the HIV Nutrition News Update List at <http://hivresources.com/mailman/listinfo/hivnutritionnewsupdatelist_hivresources.com>. Disclaimer- HIV ReSources neither endorses nor opposes any material. Information in this news update should not be construed as an endorsement of any kind. Comments are offered for general guidance only. This information is not intended to replace professional medical advice. Information is designed to support the relationship that exists between you and your doctor. Any use of this information is done strictly on your own risk and no responsibility is implied or intended on the part of HIV ReSources Inc., the editors, authors, or the publisher. Discuss any lifestyle changes you may be considering with your physician/health care specialist. -- Sharon Ann Meyer, AS, AA, DTR President, HIV ReSources, Inc. Secretary, ADA HIV/AIDS DPG #29 "Improving the quality of life for HIV-challenged individuals through effective nutritional services." mailto:[EMAIL PROTECTED] URL's: http://www.hivresources.com http://www.geocities.com/HotSprings/Villa/2998 http://www.gate.net/~sameyer http://numedx.com/nutrition/index.phtml
| <-- __Chronological__ --> | <-- __Thread__ --> |